Skip to NavigationSkip to content

long covid

Long COVID: 15 studies launched with £19.6 million government funding

The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate the condition, improve diagnosis, and find new treatments.

The programme will allow researchers across the UK to draw together their expertise from analysing long COVID among those suffering long-term effects and the health and care professionals supporting them.

So far, the effects of long COVID are still understudied and unknown. The projects will focus on the following areas:

Survey reveals over 2 million people impacted by long COVID in UK

Photo by Andrea Piacquadio from Pexels

A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered from long lasting COVID-19 symptoms.

The REACT study, which was granted £5.5 million from the UK government, assessed self-reported data from 508,707 adults, finding that 5.8% of the whole study population had suffered from symptoms lasting over 12 weeks.

‘Long COVID’ could be taking four different forms

Photo by the CDC

People experiencing chronic illnesses after COVID-19 infections could be suffering from one of four separate conditions, according to new research.

This was conducted by the National Institute for Health Research, which said thousands could be living with long-term conditions linked to COVID-19 infections.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches